Metraipolis › archive › dc_5fdaa581dd17
PARPs and PARP inhibitors: molecular mechanisms and clinical applications — Europe PMC PMID:41460301
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41460301
- DOI
- 10.1186/s43556-[numero omesso]-1
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T08:23:16.845Z
- SHA-256 of the archived text
ac48e087fb6cd37c1fa4910a3a86e7d1c2c367693c2456f313d25ebdb352f05d- Stable URL of this page
https://metraipolis.com/documento/dc_5fdaa581dd17
How to cite
PARPs and PARP inhibitors: molecular mechanisms and clinical applications — Europe PMC PMID:41460301 — Europe PMC (en), https://europepmc.org/article/MED/41460301 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5fdaa581dd17 (Metraipolis archive dc_5fdaa581dd17, sha256 ac48e087fb6cd37c1fa4910a3a86e7d1c2c367693c2456f313d25ebdb352f05d)
BibTeX
@misc{dc5fdaa581dd17,
title = {PARPs and PARP inhibitors: molecular mechanisms and clinical applications — Europe PMC PMID:41460301},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41460301},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5fdaa581dd17; sha256 ac48e087fb6cd37c1fa4910a3a86e7d1c2c367693c2456f313d25ebdb352f05d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41460301. Agents can read the archived copy with the MCP tool read_document.